Genomictree Inc. (KOSDAQ:228760)
12,030
+30 (0.25%)
Jun 27, 2025, 3:30 PM KST
Genomictree Revenue
Genomictree had revenue of 316.49M KRW in the quarter ending March 31, 2025, with 11.17% growth. This brings the company's revenue in the last twelve months to 2.39B, down -5.64% year-over-year. In the year 2024, Genomictree had annual revenue of 2.36B, down -30.89%.
Revenue (ttm)
2.39B
Revenue Growth
-5.64%
P/S Ratio
123.23
Revenue / Employee
n/a
Employees
n/a
Market Cap
295.01B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
Peptron | 4.30B |